乙胺丁醇
肺结核
药品
医学
药理学
利福平
病理
作者
Lu Zhang,Yao Zhao,Yan Gao,Lijie Wu,Ruogu Gao,Qi Zhang,Yinan Wang,Chengyao Wu,Fang-Yu Wu,Sudagar S. Gurcha,Natacha Veerapen,Sarah M. Batt,Wei Zhao,Ling Qin,Xiuna Yang,Manfu Wang,Yan Zhu,Bing Zhang,Lijun Bi,Xian‐En Zhang
出处
期刊:Science
[American Association for the Advancement of Science]
日期:2020-04-23
卷期号:368 (6496): 1211-1219
被引量:125
标识
DOI:10.1126/science.aba9102
摘要
The arabinosyltransferases EmbA, EmbB, and EmbC are involved in Mycobacterium tuberculosis cell wall synthesis and are recognized as targets for the anti-tuberculosis drug ethambutol. In this study, we determined cryo-electron microscopy and x-ray crystal structures of mycobacterial EmbA-EmbB and EmbC-EmbC complexes in the presence of their glycosyl donor and acceptor substrates and with ethambutol. These structures show how the donor and acceptor substrates bind in the active site and how ethambutol inhibits arabinosyltransferases by binding to the same site as both substrates in EmbB and EmbC. Most drug-resistant mutations are located near the ethambutol binding site. Collectively, our work provides a structural basis for understanding the biochemical function and inhibition of arabinosyltransferases and the development of new anti-tuberculosis agents.
科研通智能强力驱动
Strongly Powered by AbleSci AI